Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ZTS Zoetis Inc climbs 281 percent after Q4 2025 earnings per share exceed analyst forecasts Will Brighthouse BHFAM stock drop more today 4625 Series D preferred depositary shares post 298 EPS miss SAMG Silvercrest Asset Management Group Inc posts Q4 2025 earnings miss even as its stock trades slightly higher in todays session TXG 10x Genomics posts narrower than expected Q4 2025 loss shares rise 172 percent on positive investor sentiment How 1RT ONCHU margins compare to industry leaders 013 20260508 FLD Fold Holdings posts far wider than expected Q4 2025 loss shares stay flat with no reported quarterly revenue WOOF Petco beats earnings estimates by 65 despite revenue slide shares rise modestly on cost discipline Roundhill Memory ETF Surpasses 10 Billion as AI Chip Demand Drives Record Growth Jim Cramer Weighs In on Atlassians YouTube Controversy Prediction Markets and Crypto Firms Overcome Regulatory Scrutiny Report Suggests Nifty Futures and Bank Nifty Futures Face Firm Resistance as Bearish Conviction Eases IEA Chief Warns Oil Markets May Enter Red Zone by MidSummer Amid Iran Crisis ADP Private Payrolls Rise 109000 in April Exceeding Market Forecasts AEBI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Reaction NUVB Q1 2026 Earnings Narrow EPS Beat Reflects Continued Pipeline Progress MDIA Q3 2023 Earnings Negative EPS Amidst Ongoing Industry Challenges LOCO Q1 2026 Earnings EPS Surpasses Estimates by Over 27 Despite Revenue Uncertainty AVD Q3 2025 Earnings Significant EPS Miss Weighs on Shares FITBP Q1 2026 Earnings Strong EPS Beat of 3509 Surprise Drives Modest Stock Gain Banzai International Warrant BNZIW Shows Modest Gains Amid LowPriced Trading SEATW Holds Steady at 006 Amid Minimal Activity Vivid Seats Warrant Remains RangeBound BioAge Labs BIOA Slightly Declines as Biotech Sector Faces Mixed Sentiment Bloomin Brands Stock Dips 243 Testing Support Levels Amid Market Pressures TransCode Therapeutics RNAZ Drops 1066 Support at 53 Faces Critical Test After Sharp Decline